Ventyx Biosciences VTYX Stock
Ventyx Biosciences Price Chart
Ventyx Biosciences VTYX Financial and Trading Overview
| Ventyx Biosciences stock price | 0.94 USD |
| Previous Close | 35.04 USD |
| Open | 34.84 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 800 |
| Day's Range | 33.37 - 35.07 USD |
| 52 Week Range | 11.07 - 47.25 USD |
| Volume | 465.26K USD |
| Avg. Volume | 818.25K USD |
| Market Cap | 1.96B USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.97 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 57.58 USD |
VTYX Valuation Measures
| Enterprise Value | 1.68B USD |
| Trailing P/E | N/A |
| Forward P/E | -10.440625 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.2457213 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -12.623 |
Trading Information
Ventyx Biosciences Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 138.64% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 47.25 USD |
| 52 Week Low | 11.07 USD |
| 50-Day Moving Average | 35 USD |
| 200-Day Moving Average | 34.04 USD |
VTYX Share Statistics
| Avg. Volume (3 month) | 818.25K USD |
| Avg. Daily Volume (10-Days) | 641.13K USD |
| Shares Outstanding | 58.56M |
| Float | 43.53M |
| Short Ratio | 12.79 |
| % Held by Insiders | 3.83% |
| % Held by Institutions | 90.93% |
| Shares Short | 8.29M |
| Short % of Float | 21.39% |
| Short % of Shares Outstanding | 14.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.90% |
| Return on Equity (ttm) | -39.51% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -132808000 USD |
| Net Income Avi to Common (ttm) | -124625000 USD |
| Diluted EPS (ttm) | -2.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 376.92M USD |
| Total Cash Per Share (mrq) | 6.44 USD |
| Total Debt (mrq) | 1.46M USD |
| Total Debt/Equity (mrq) | 0.39 USD |
| Current Ratio (mrq) | 23.436 |
| Book Value Per Share (mrq) | 6.369 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -116966000 USD |
| Levered Free Cash Flow (ttm) | -71579128 USD |
Profile of Ventyx Biosciences
| Country | United States |
| State | CA |
| City | Encinitas |
| Address | 662 Encinitas Blvd. |
| ZIP | 92024 |
| Phone | 760-593-4832 |
| Website | https://ventyxbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 76 |
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. Its lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.
Q&A For Ventyx Biosciences Stock
What is a current VTYX stock price?
Ventyx Biosciences VTYX stock price today per share is 0.94 USD.
How to purchase Ventyx Biosciences stock?
You can buy VTYX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ventyx Biosciences?
The stock symbol or ticker of Ventyx Biosciences is VTYX.
Which industry does the Ventyx Biosciences company belong to?
The Ventyx Biosciences industry is Biotechnology.
How many shares does Ventyx Biosciences have in circulation?
The max supply of Ventyx Biosciences shares is 71.13M.
What is Ventyx Biosciences Price to Earnings Ratio (PE Ratio)?
Ventyx Biosciences PE Ratio is now.
What was Ventyx Biosciences earnings per share over the trailing 12 months (TTM)?
Ventyx Biosciences EPS is -1.97 USD over the trailing 12 months.
Which sector does the Ventyx Biosciences company belong to?
The Ventyx Biosciences sector is Healthcare.
Ventyx Biosciences VTYX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ Biotechnology NBI | 3904.12 USD — |
-5.49
|
— — | 3901.51 USD — | 4064.61 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 1938.96 USD — |
-4.51
|
— — | 1891.68 USD — | 1965.66 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7625.89 USD — |
-5.84
|
— — | 7621.56 USD — | 7894.21 USD — | — - | — — |
- {{ link.label }} {{link}}